Allopurinol
CAS number： 315-30-0
Molecular formula： C5H4N4O
molecular weight： 136.11
Chemical structure：
Producers shown on SFDA
(Record date:05/09/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
Jiangsu Yew Pharmaceutical Co., Ltd. | GMP, DMF | Valid till May 2024 |
Chongqing Southwest Synthetic Pharmaceutical Co., Ltd. | GMP | Valid till February 2022 |
Heilongjiang Maizhilun Pharmaceutical Co., Ltd. | GMP | Valid till December 2020 |
Producers shown on EP
(Quoted from EP website；record date:05/09/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Allopurinol | TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva | R1-CEP 1998-118-Rev 06 | 13/05/2014 | VALID | / | Chemistry |
| Allopurinol Allopurinol P-process | TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva | R1-CEP 2014-117-Rev 00 | 13/12/2019 | VALID | / | Chemistry |
| Allopurinol Synthetic route B | EGIS Pharmaceuticals PLC HU 1106 Budapest | R1-CEP 2014-364-Rev 00 | 08/01/2021 | VALID | / | Chemistry |
Producer:Wuxi Taxus Pharmaceutical Co., Ltd. (formerly Jiangsu Yew Pharmaceutical Co., Ltd.) was established in 2004. It is a pharmaceutical enterprise subordinate to Hongdou Group in the field of big health industry,.
The API factory has built a standard workshop of 28800 square meters according to GMP standards, has advanced automatic production lines at home and abroad, and is equipped with a full set of raw material processing equipment, advanced testing instruments and supporting sewage treatment system. A complete set of processing technology from paclitaxel crude products to high-quality products has been formed, and more than 300 kg of paclitaxel finished products can be extracted every year. The preparation factory adopts advanced and standardized GMP design concept, selects international production equipment and testing instruments, and can produce various specifications of anti-tumor drug injection and freeze-dried powder injection, with an annual production of 6 million anti-tumor drug injections.
Registered capital:RMB 80 million
Producer:Chongqing Southwest Synthetic Pharmaceutical Co., Ltd., founded in 1965 (formerly known as Southwest Synthetic Pharmaceutical Factory), is now controlled by Peking University Founder group. The company has a complete product structure, mainly including more than 10 categories, including sulfonamides, antipyretics and analgesics, total anti and semi synthetic anti, vitamins, quinolones, anti ulcer drugs, anti anxiety drugs, antihypertensive drugs, anti allergic drugs, antiemetic drugs, anticancer drugs, cardiovascular drugs and more than 100 varieties of APIs and preparations. All products of Southwest synthesis have passed GMP certification, of which 7 products have passed FDA certification and 5 products have obtained European cos certificate.
Staff size:/
Registered capital:RMB 250 million
Producer:Heilongjiang Maizhilun Pharmaceutical Co., Ltd. was established in 2009. Its main industry is manufacturing. The company's business scope includes: manufacturing of API (soybean phospholipid powder, sodium azulene sulfonate, allopurinol), etc
Staff size:About 50 persons
Registered capital:RMB 5 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE